Literature DB >> 10742410

Escherichia coli O157:H7-induced hemolytic-uremic syndrome: histopathologic changes in the colon over time.

K F Murray1, K Patterson.   

Abstract

The 1993 E. coli O157:H7 epidemic in the Western United States has provided a unique opportunity to evaluate the histopathologic temporal progression of disease in the colon in children who developed hemolytic uremic syndrome (HUS). In this report we briefly summarize the clinical courses of eight patients and then discuss the colonic pathology observed in specimens obtained at surgery or at the time of autopsy. The patients were divided into two groups: group 1 consisted of six subjects whose colonic samples were obtained during the acute phase of disease, and group 2 consisted of two subjects whose samples were obtained late in their disease. Both the gross and microscopic findings showed that the most severely affected as well as the earliest affected regions of the colon were the left and transverse portions. Only later in the disease progression was there right-sided colon involvement. These findings are in contrast to the distribution described in E. coli O157:H7 hemorrhagic colitis without HUS, thus suggesting a different mechanism of injury.

Entities:  

Mesh:

Year:  2000        PMID: 10742410     DOI: 10.1007/s100249910030

Source DB:  PubMed          Journal:  Pediatr Dev Pathol        ISSN: 1093-5266


  6 in total

1.  Escherichia coli O157:H7.

Authors:  E Weir
Journal:  CMAJ       Date:  2000-07-25       Impact factor: 8.262

Review 2.  Chronic sequelae of E. coli O157: systematic review and meta-analysis of the proportion of E. coli O157 cases that develop chronic sequelae.

Authors:  Jessica Keithlin; Jan Sargeant; M Kate Thomas; Aamir Fazil
Journal:  Foodborne Pathog Dis       Date:  2013-11-27       Impact factor: 3.171

3.  Restricted expression of shiga toxin binding sites on mucosal epithelium of mouse distal colon.

Authors:  Yasuyuki Imai; Takashi Fukui; Kohta Kurohane; Daisei Miyamoto; Yasuo Suzuki; Tomoyuki Ishikawa; Yousuke Ono; Masaki Miyake
Journal:  Infect Immun       Date:  2003-02       Impact factor: 3.441

4.  Macropinocytosis in Shiga toxin 1 uptake by human intestinal epithelial cells and transcellular transcytosis.

Authors:  Irina Malyukova; Karen F Murray; Chengru Zhu; Edgar Boedeker; Anne Kane; Kathleen Patterson; Jeffrey R Peterson; Mark Donowitz; Olga Kovbasnjuk
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-10-30       Impact factor: 4.052

5.  Shiga toxin 1 interaction with enterocytes causes apical protein mistargeting through the depletion of intracellular galectin-3.

Authors:  Marina Laiko; Rakhilya Murtazina; Irina Malyukova; Chengru Zhu; Edgar C Boedeker; Oksana Gutsal; Robert O'Malley; Robert N Cole; Phillip I Tarr; Karen F Murray; Anne Kane; Mark Donowitz; Olga Kovbasnjuk
Journal:  Exp Cell Res       Date:  2009-09-08       Impact factor: 3.905

6.  Shiga Toxins Induce Apoptosis and ER Stress in Human Retinal Pigment Epithelial Cells.

Authors:  Jun-Young Park; Yu-Jin Jeong; Sung-Kyun Park; Sung-Jin Yoon; Song Choi; Dae Gwin Jeong; Su Wol Chung; Byung Joo Lee; Jeong Hun Kim; Vernon L Tesh; Moo-Seung Lee; Young-Jun Park
Journal:  Toxins (Basel)       Date:  2017-10-13       Impact factor: 4.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.